Source note2 min read

Do Language Models Dream of Binding Molecules? Benchmarking LLMs under Spatial Constraints

Source

arXiv

arxiv.org/abs/2607.18144v1

Read the source

Source

  • Source name: arXiv
  • Source kind: paper
  • Authors / organization: Thomas MacDougall, Maksim Kuznetsov, Roman Schutski, Rim Shayakhmetov, Maxim Malkov, Vladimir Aladinskiy, Alex Aliper, Alex Zhavoronkov
  • Venue: arXiv: cs.LG
  • Published: 2026-07-20
  • Collected: 2026-07-21
  • URL: http://arxiv.org/abs/2607.18144v1
  • PDF: https://arxiv.org/pdf/2607.18144v1
  • DOI: UNKNOWN

Plain-Language Brief

In the study titled 'Do Language Models Dream of Binding Molecules? Benchmarking LLMs under Spatial Constraints', the authors examine the ability of large language models (LLMs) to navigate complex 3D spatial constraints in structure-based drug design compared to established diffusion models. The authors find that while LLMs currently lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously.

What the Document Says

  • The study is about the use of large language models (LLMs) in structure-based drug design under complex 3D spatial constraints.
  • LLMs are compared to established diffusion models for generating candidate binding molecules with spatial constraints.
  • Spatial constraints include anchor fragments, pharmacophore points, mandatory pocket-ligand interactions, and ligand-derived spatial constraints.
  • The authors introduce 3D-Fit, a token-efficient benchmarking strategy for assessing LLM performance on multi-conditioned spatial molecule generation.
  • The findings show that while LLMs lag behind state-of-the-art approaches, they can handle multiple spatial constraints simultaneously and are promising.

Key Concepts Mentioned

  • Large Language Models (LLMs)
  • Structure-based drug design
  • 3D spatial constraints
  • Diffusion models
  • Anchor fragments
  • Pharmacophore points
  • Mandatory pocket-ligand interactions

Claims Made by the Document

  • Current LLMs can navigate complex 3D spatial constraints.
  • LLMs lag behind state-of-the-art approaches but show promise.
  • LLMs can handle multiple spatial constraints simultaneously.

Evidence Used

  • The authors introduce a benchmarking strategy (3D-Fit) and analyze the performance of LLMs under various spatial constraints.

Methods / Approach

  • Introduction of 3D-Fit, a token-efficient benchmarking strategy for assessing LLM performance on multi-conditioned spatial molecule generation.

Limitations Stated by the Authors

The authors acknowledge that current LLMs still lag behind state-of-the-art approaches in navigating complex 3D spatial constraints.

Limitations Noted by the Agent

Agent interpretation — not from the source.

The study only examines the ability of LLMs to reason about physics and 3D spatial environments in structure-based drug design. Other applications or aspects may have different limitations.

Open Questions

  • What are the potential future improvements for LLMs in navigating complex 3D spatial constraints?

Notes for Future Q&A

May include interpretation. Labeled where it does.

The study does not discuss the specific LLM models used, nor the comparison methodology with other LLM models.

Raw Abstract / Excerpt

Structure-based drug design (SBDD) leverages the 3D structure of protein targets, often complemented by other spatial constraints, to generate candidate binding molecules. While diffusion models have dominated as a leading paradigm for high-quality 3D molecule generation, LLM-based methods are rapidly emerging in molecular design and have shown competitive performance in pocket-conditioned molecular generation. However, their ability to reason about physics and 3D spatial environments is largely underexplored. In this work, we systematically analyze whether current general-purpose LLMs are capable of navigating complex 3D constraints compared to established baselines such as specialized diffusion models. We consider 3D ligand generation conditioned on protein pockets together with ligand- and interaction-derived spatial constraints, including anchor fragments, pharmacophore points, and mandatory pocket-ligand interactions. To enable this evaluation, we introduce 3D-Fit - a token-efficient benchmarking strategy for assessing LLM performance on multi-conditioned spatial molecule generation. Our findings reveal a clear pattern in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.